These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10872880)

  • 21. A novel parainfluenza virus type 3 (PIV3) identified from goat herds with respiratory diseases in eastern China.
    Li W; Mao L; Cheng S; Wang Q; Huang J; Deng J; Wang Z; Zhang W; Yang L; Hao F; Ding Y; Sun Y; Wei J; Jiang P; Jiang J
    Vet Microbiol; 2014 Nov; 174(1-2):100-6. PubMed ID: 25236986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.
    Lingemann M; Surman S; Amaro-Carambot E; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Mar; 89(6):3318-31. PubMed ID: 25589643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: comparison with the Wash/47885/57 prototype strain.
    Stokes A; Tierney EL; Murphy BR; Hall SL
    Virus Res; 1992 Sep; 25(1-2):91-103. PubMed ID: 1329377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus type 3 fusion glycoprotein gene.
    Côté MJ; Storey DG; Kang CY; Dimock K
    J Gen Virol; 1987 Apr; 68 ( Pt 4)():1003-10. PubMed ID: 3033123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of three antigen epitopes on the nucleocapsid protein of the genotype C of bovine parainfluenza virus type 3.
    Ren JL; Zhu YM; Zhou YH; Lv C; Yan H; Ma L; Shi HF; Xue F
    Vet Microbiol; 2015 Jul; 178(1-2):61-9. PubMed ID: 25960335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of infectious human parainfluenza virus type 3 from cDNA.
    Durbin AP; Hall SL; Siew JW; Whitehead SS; Collins PL; Murphy BR
    Virology; 1997 Sep; 235(2):323-32. PubMed ID: 9281512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins.
    Skiadopoulos MH; Surman SR; Riggs JM; Orvell C; Collins PL; Murphy BR
    Virology; 2002 May; 297(1):136-52. PubMed ID: 12083844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.
    Karron RA; Thumar B; Schappell E; Surman S; Murphy BR; Collins PL; Schmidt AC
    Vaccine; 2012 Jun; 30(26):3975-81. PubMed ID: 22178099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Construction and rescue of the minigenome of bovine parainfluenza virus type 3 based on T7 promoter expression system].
    Jiang N; Zheng Y; Jiang G; Zhang W; Jiao `; Fu Y; Peng X; He J
    Wei Sheng Wu Xue Bao; 2016 Nov; 56(11):1746-54. PubMed ID: 29741838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates.
    Bukreyev A; Huang Z; Yang L; Elankumaran S; St Claire M; Murphy BR; Samal SK; Collins PL
    J Virol; 2005 Nov; 79(21):13275-84. PubMed ID: 16227250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
    Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
    Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
    J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3).
    Stokes A; Tierney EL; Sarris CM; Murphy BR; Hall SL
    Virus Res; 1993 Oct; 30(1):43-52. PubMed ID: 8266719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus 3 hemagglutinin-neuraminidase gene: comparison with other paramyxoviruses.
    Storey DG; Côté MJ; Dimock K; Kang CY
    Intervirology; 1987; 27(2):69-80. PubMed ID: 2822598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective interfering particles of human parainfluenza virus 3.
    Murphy DG; Dimock K; Kang CY
    Virology; 1987 Jun; 158(2):439-43. PubMed ID: 3035791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
    Liang B; Ngwuta JO; Surman S; Kabatova B; Liu X; Lingemann M; Liu X; Yang L; Herbert R; Swerczek J; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of human parainfluenza virus type 3 obtained in Croatia, 2011-2015.
    Košutić-Gulija T; Slovic A; Ljubin-Sternak S; Mlinarić-Galinović G; Forčić D
    J Med Microbiol; 2017 Apr; 66(4):502-510. PubMed ID: 28463659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
    Tang RS; MacPhail M; Schickli JH; Kaur J; Robinson CL; Lawlor HA; Guzzetta JM; Spaete RR; Haller AA
    J Virol; 2004 Oct; 78(20):11198-207. PubMed ID: 15452239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a photocontrollable recombinant bovine parainfluenza virus type 3.
    Okura T; Tahara M; Otsuki N; Sato M; Takeuchi K; Takeda M
    Microbiol Immunol; 2023 Apr; 67(4):204-209. PubMed ID: 36609846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of vaccines for parainfluenza virus infections.
    Sato M; Wright PF
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S123-5. PubMed ID: 18820572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.